Renee Cottle is an associate professor of Bioengineering at Clemson University. She earned her Ph.D. in Biomedical Engineering from the Georgia Institute of Technology and Emory University in 2015. She completed a T32 Postdoctoral Fellowship in the Cardiovascular Research Program at the Medical University of South Carolina before joining Clemson University as a faculty member in 2016.

Dr. Cottle is the recipient of the 2021 AASLD Pinnacle Research Award and the ASGCT Fellowship Award in Gene and Cell Therapy. She currently serves as Principal Investigator on an NIH-funded R01 award investigating a cell-based gene editing therapy for familial hypercholesterolemia. Her research program focuses on gene editing, gene therapy, and non-viral delivery strategies, with a central goal of overcoming key technical challenges to develop innovative cell-based therapies for inherited metabolic diseases affecting the liver.